Morten Isaksen, Ph.D.
Company: Bio-Me AS
Job title: CEO
Precision Microbiome Profiling as a Tool to Support Successful Clinical Development and Market Introduction of Microbiome Modulating Drugs 12:30 pm
• How to translate discoveries from Next Generation Sequencing into rapid and accurate microbiome profiling • The benefits of rapid turnaround time in clinical development programs and final clinical applications • The importance of absolute quantification at species and subspecies level for optimal microbiome profiling • Examples of practical applicationsRead more
day: Day Two – Track B – 1